Back to SLNCF
Tetragon Partners GP Ltd → SLNCF
Tetragon Partners GP Ltd SLNCF Position History
Silence Therapeutics plc • Healthcare
Quarters held
6
Latest value
$26.6M
Q3 2026
Peak value
$26.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.2M |
| Q1 2026 | $3.3M |
| Q2 2026 | $3.3M |
| Q2 2026 | $8.4M |
| Q3 2026 | $5.5M |
| Q3 2026 | $26.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $26.6M | 2.44M | — | — |
| Q3 2026 | $5.5M | 500.0K | — | — |
| Q2 2026 | $8.4M | 764.3K | — | — |
| Q2 2026 | $3.3M | 300.0K | — | — |
| Q1 2026 | $3.3M | 630.2K | — | — |
| Q4 2025 | $2.2M | 365.4K | — | — |
Other funds holding SLNCF
$44.5M
$36.4M
$31.6M
$29.4M
$26.9M